10/02/2024
4:20 PM | Reneo Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/02/2024
4:23 PM | Reneo Pharmaceuticals (Subject)
| Form 425 | |
09/26/2024
8:33 AM | Leonard Braden Michael (Reporting)
Reneo Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2024
6:04 AM | Reneo Pharmaceuticals (Subject)
| Form 425 | |
09/20/2024
6:00 AM | Reneo Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/19/2024
10:02 AM | Leonard Braden Michael (Reporting)
Reneo Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
3:21 PM | Reneo Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
08/26/2024
11:15 PM | Reneo Pharmaceuticals (Filer)
| Form EFFECT | |
08/26/2024
4:06 PM | Reneo Pharmaceuticals (Filer)
| Form 424B3 | |
08/26/2024
4:06 PM | Reneo Pharmaceuticals (Filer)
| Form 424B3 | |
08/26/2024
5:10 AM | Reneo Pharmaceuticals (Filer)
| Form S-4/A | |
08/19/2024
5:06 AM | Reneo Pharmaceuticals (Filer)
| Form S-4/A | |
08/14/2024
7:48 PM | Leonard Braden Michael (Reporting)
Reneo Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/26/2024
8:59 PM | Reneo Pharmaceuticals (Filer)
| Form S-4/A | |
05/21/2024
9:12 AM | BML Investment Partners, L.P. (Filed by)
Reneo Pharmaceuticals (Subject)
| Form SC 13G/A | |
05/16/2024
7:56 AM | Leonard Braden Michael (Reporting)
Reneo Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/16/2024
7:58 AM | Leonard Braden Michael (Reporting)
Reneo Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2024
8:14 AM | Reneo Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
8:38 AM | Reneo Pharmaceuticals (Subject)
| Form 425 | |
04/26/2024
5:16 AM | Reneo Pharmaceuticals (Filer)
| Form 10-K/A | |
03/28/2024
3:05 PM | Reneo Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/28/2024
3:00 PM | Reneo Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2024
3:01 PM | Reneo Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/05/2024
3:01 PM | Octagon Capital Advisors LP (Filed by)
Reneo Pharmaceuticals (Subject)
| Form SC 13G | |
12/26/2023
4:00 PM | Reneo Pharmaceuticals (Subject)
TANG CAPITAL PARTNERS LP (Filed by)
| Form SC 13D | |
12/15/2023
3:55 PM | Novo Holdings A/S (Filed by)
Reneo Pharmaceuticals (Subject)
| Form SC 13D/A | |
12/14/2023
8:26 AM | Reneo Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/21/2023
11:15 PM | Reneo Pharmaceuticals (Filer)
| Form EFFECT | |
11/13/2023
3:58 PM | Reneo Pharmaceuticals (Filer)
| Form 424B5 | |
11/13/2023
4:08 PM | Reneo Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
10/30/2023
3:47 PM | Reneo Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/10/2023
5:08 AM | Reneo Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
